Phase II trial of cenderitide in hospitalised patients with acute decompensated heart failure.
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2012
At a glance
- Drugs Cenderitide (Primary)
- Indications Decompensated heart failure
- Focus Therapeutic Use
- Sponsors Nile Therapeutics
- 05 Apr 2012 Planned initiation date changed from 1 Jan 2012 to 1 Jun 2012.
- 02 Mar 2011 New trial record